⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for bcc

Every month we try and update this database with for bcc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
AI-aided Optical Coherence Tomography for the Detection of Basal Cell CarcinomaNCT05817279
Basal Cell Carc...
Optical Coheren...
Optical coheren...
18 Years - Maastricht University Medical Center
Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell CarcinomaNCT03889912
Cutaneous Squam...
Basal Cell Carc...
Cemiplimab
18 Years - Regeneron Pharmaceuticals
An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCCNCT04155190
Recurrent Basal...
Patidegib Topic...
Patidegib Topic...
18 Years - Sol-Gel Technologies, Ltd.
CellFX Treat & Resect Low-Risk BCC Feasibility StudyNCT04918381
BCC - Basal Cel...
BCC
Excision Margin
CellFX System
22 Years - 85 YearsPulse Biosciences, Inc.
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)NCT00581425
Basal Cell Carc...
Imiquimod and I...
- The University of Texas Health Science Center, Houston
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell CarcinomaNCT06150144
Basal Cell Carc...
BCC
5-Fluorouracil
SURGERY
- University of Aleppo
Pilot Study of PDL to Treat BCC and SCCISNCT01245972
Basal Cell Carc...
Squamous Cell C...
PDL Treatment
18 Years - University of California, San Diego
Use of Jet-injection in Photodynamic Therapy for Basal Cell CarcinomaNCT04552990
BCC
BCC - Basal Cel...
Basal Cell Carc...
Basal Cell Canc...
Superficial Bas...
Nodular Basal C...
Jet injection o...
Surgical excisi...
Illumination
Incubation
18 Years - Memorial Sloan Kettering Cancer Center
Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's TumorsNCT00449358
Basal Cell Carc...
apply methyl-AL...
18 Years - Assuta Hospital Systems
An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCCNCT04155190
Recurrent Basal...
Patidegib Topic...
Patidegib Topic...
18 Years - Sol-Gel Technologies, Ltd.
Pilot Study of PDL to Treat BCC and SCCISNCT01245972
Basal Cell Carc...
Squamous Cell C...
PDL Treatment
18 Years - University of California, San Diego
HIFU for Treatment of Non-nodular and Recurrent BCCNCT05133427
Carcinoma, Basa...
TOOsonix system...
18 Years - Bispebjerg Hospital
A Beta-only IL-2 ImmunoTherapY StudyNCT05086692
Advanced Solid ...
Unresectable So...
Clear Cell Rena...
Triple Negative...
Non-Small Cell ...
Non-Small Cell ...
Colorectal Canc...
Gastric Cancer
Cervical Cancer
Basal Cell Carc...
Bladder Cancer
Merkel Cell Car...
Squamous Cell C...
Cutaneous Squam...
Pleural Mesothe...
Esophageal Canc...
Endometrial Car...
Solid Tumor
Solid Tumor, Ad...
MSI-H Solid Mal...
Cancer With A H...
Epithelial Ovar...
Primary Periton...
Gastroesophagea...
Acral Melanoma
Mucosal Melanom...
Cutaneous Melan...
DMMR Solid Mali...
Fallopian Tube ...
Ovarian Cancer
MSI-H Cancer
DMMR Cancer
Pancreas Adenoc...
Skin Cancer
MDNA11
Pembrolizumab
18 Years - Medicenna Therapeutics, Inc.
Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)NCT04308395
Basal Cell Nevu...
Patidegib Topic...
18 Years - Sol-Gel Technologies, Ltd.
Open-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaNCT05188729
Basal Cell Carc...
Skin Cancer
Cancer of the S...
Cancer of the S...
Carcinoma
LTX-315 Part 1
VP-315 Part 2
18 Years - Verrica Pharmaceuticals Inc.
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)NCT00581425
Basal Cell Carc...
Imiquimod and I...
- The University of Texas Health Science Center, Houston
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell CarcinomaNCT00108121
Basal Cell Carc...
PEP005
18 Years - Peplin
Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell CarcinomaNCT04669808
Basal Cell Carc...
STP705
18 Years - Sirnaomics
Safety and Efficacy of AIV001 on Low Risk Basal Cell CarcinomaNCT04470726
Superficial Bas...
Nodular Basal C...
AIV001
18 Years - 80 YearsAiViva BioPharma, Inc.
Open-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaNCT05188729
Basal Cell Carc...
Skin Cancer
Cancer of the S...
Cancer of the S...
Carcinoma
LTX-315 Part 1
VP-315 Part 2
18 Years - Verrica Pharmaceuticals Inc.
Skin Cancer and Hyperthermia and RadiotherapyNCT06384053
Basal Cell Carc...
Squamous Cell C...
Non-melanoma Sk...
Water-filtered ...
Radiotherapy (R...
65 Years - Kantonsspital Winterthur KSW
Pilot Study of PDL to Treat BCC and SCCISNCT01245972
Basal Cell Carc...
Squamous Cell C...
PDL Treatment
18 Years - University of California, San Diego
Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)NCT02354261
Basal Cell Carc...
SUBA-Itraconazo...
18 Years - HedgePath Pharmaceuticals, Inc.
High Intensity Focused Ultrasound (HIFU) Treatment of Basal Cell CarcinomaNCT05698706
Basal Cell Carc...
TOOsonix System...
18 Years - Old Town Clinic, Poland
A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell CarcinomaNCT01327053
Basal Cell Carc...
LDE225
18 Years - Novartis
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell CarcinomaNCT00108134
Basal Cell Carc...
PEP005
18 Years - Peplin
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell CarcinomaNCT06150144
Basal Cell Carc...
BCC
5-Fluorouracil
SURGERY
- University of Aleppo
A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell CarcinomaNCT00833417
Basal Cell Carc...
Vismodegib 150 ...
18 Years - Genentech, Inc.
CellFX Treat & Resect Low-Risk BCC Feasibility StudyNCT04918381
BCC - Basal Cel...
BCC
Excision Margin
CellFX System
22 Years - 85 YearsPulse Biosciences, Inc.
Safety and Efficacy of AIV001 on Low Risk Basal Cell CarcinomaNCT04470726
Superficial Bas...
Nodular Basal C...
AIV001
18 Years - 80 YearsAiViva BioPharma, Inc.
AI-aided Optical Coherence Tomography for the Detection of Basal Cell CarcinomaNCT05817279
Basal Cell Carc...
Optical Coheren...
Optical coheren...
18 Years - Maastricht University Medical Center
Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell CarcinomaNCT04669808
Basal Cell Carc...
STP705
18 Years - Sirnaomics
Molecular Characterization of Cutaneous TumorsNCT03092830
Squamous Cell C...
Basal Cell Carc...
Molecular testi...
18 Years - Rabin Medical Center
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic CancerNCT04916002
Merkel Cell Car...
Cutaneous Squam...
Basal Cell Carc...
Triple Negative...
Non-Small Cell ...
Oropharynx Squa...
vidutolimod
cemiplimab
18 Years - Regeneron Pharmaceuticals
Use of Jet-injection in Photodynamic Therapy for Basal Cell CarcinomaNCT04552990
BCC
BCC - Basal Cel...
Basal Cell Carc...
Basal Cell Canc...
Superficial Bas...
Nodular Basal C...
Jet injection o...
Surgical excisi...
Illumination
Incubation
18 Years - Memorial Sloan Kettering Cancer Center
High Intensity Focused Ultrasound (HIFU) Treatment of Basal Cell CarcinomaNCT05698706
Basal Cell Carc...
TOOsonix System...
18 Years - Old Town Clinic, Poland
Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell CarcinomaNCT04669808
Basal Cell Carc...
STP705
18 Years - Sirnaomics
Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)NCT04308395
Basal Cell Nevu...
Patidegib Topic...
18 Years - Sol-Gel Technologies, Ltd.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: